Marker; Structural

2

Review clinical trials related to Marker; Structural. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors

The purpose of this research study is to investigate whether cancer survivors have higher levels of proteins called Fatty Acid Binding Proteins as well as 12 different markers of cellular senescence than people who have never had cancer. Investigators believe that these levels may be elevated in cancer survivors as a result of their cancer and the treatments they received and may put them at higher risk for chronic conditions such as high cholesterol, diabetes, high blood pressure, and obesity. This study will also compare the levels of these proteins and inflammatory markers in the blood with different aspects of cancer treatment the survivors received. Investigators are investigating if there is a correlation between levels of these proteins and markers, the type of treatment cancer survivors received, and development of metabolic conditions.

Participants needed: 120
Trial details
Age: 5-50Biological sex: AllType: ObservationalSponsor: Case Comprehensive Cancer CenterUpdated: Jul 1, 2026Locations: 1
Eligibility criteria

Diagnosis of at least one malignancy for which chemotherapy, radiation, and/or s... [+2]

Pregnancy at the time of the study [+12]

Status: Not yet recruiting

Effects of Lifestyle Intervention in the Biological Aging in Prediabetes

Lifestyle modifications, including dietary changes and increased physical activity, play a crucial role in controlling complications to reduce or eliminate them. As well as controlling disturbances in biochemical markers such as DNAm PhenoAge, and signs of aging such as circulating sclerostin (SOST) and growth differentiation factor 15 (GDF15). This study seeks to address this dilemma by focusing on specific groups of elderly Saudis with prediabetes . Lifestyle changes in elderly Saudis with prediabetes show promise in reducing or eliminating complications. The potential insights derived from this research extend beyond academia, offering tangible benefits for clinical practice and public health The proposed study will be implemented to achieve the following objective: 1. To determine changes in DNAm PhenoAge of elderly Saudis with prediabetes who underwent a 6-month lifestyle modification program. 2. To determine changes in other candidate senescence markers such as circulating sclerostin (SOST) and growth differentiation factor 15 (GDF15) of elderly Saudis with prediabetes who underwent a 6-month lifestyle modification program.

Participants needed: 500
Trial details
Age: 30-80Biological sex: AllType: InterventionalSponsor: King Saud UniversityUpdated: Jun 11, 2024
Eligibility criteria

Clinical diagnosis of pre-diabetes for all Saudis aged 30 years and above, males... [+1]

Insulin-dependent diabetes and non-diabetic patients [+1]